Results 181 to 190 of about 210,635 (269)

Medroxyprogesterone acetate vs. GnRH antagonist for preventing premature LH surge during ovarian stimulation in assisted reproductive technology: a retrospective cohort study. [PDF]

Front Reprod Health
Jimenez MM, Jesam C, Sequeira K, Alcantar K.   +3 more
europepmc   +1 more source

Progestin primed ovarian stimulation yields comparable outcomes to the GnRH antagonist protocol for controlled ovarian hyperstimulation. [PDF]

Sci Rep
Meseci E, Okten SB, Bilgen S, Ozveri H, Ocal N, Ozdemir B, Fıcıcıoglu C.   +6 more
europepmc   +1 more source

Impact of GnRH antagonist protocols versus progestin-primed ovarian stimulation on reproductive outcomes in advanced reproductive age women: a propensity score-matched retrospective cohort study. [PDF]

Front Endocrinol (Lausanne)
Qi Z, Wang T, Ren J, Zhao S, Song J, Lian F, Zhao Y.   +6 more
europepmc   +1 more source

An explainable machine learning model for identifying the risk of suboptimal oocyte maturation in patients with polycystic ovary syndrome undergoing GnRH-antagonist protocol. [PDF]

J Ovarian Res
Zhao L, Fan G, Wang W, Zhou C.
europepmc   +1 more source

Flexible progestin-primed ovarian stimulation is a safe and effective alternative to GnRH antagonist protocol in PGT-A cycles. [PDF]

Turk J Obstet Gynecol
Turgut NE, Özmen S, Kar E, Benli H, Bastu E.   +4 more
europepmc   +1 more source

A Case of Familial Mediterranean Fever Diagnosed After Oral Administration of a Gonadotropin-Releasing Hormone (GnRH) Antagonist. [PDF]

Cureus
Ueno H, Ohara R, Nakao S, Sasaki J, Satoh T.   +4 more
europepmc   +1 more source

GnRH Agonist with Low-Dose hCG (Dual Trigger) versus GnRH Agonist Only Trigger in High Responders in GnRH Antagonist Cycle: A Systematic Review and Meta-Analysis.

Gynecol Obstet Invest
Syam HH, Bayuaji H, Tjahyadi D, Rachmawati A, Ritonga MA, Adrianto N.   +5 more
europepmc   +1 more source

Nomogram-Based Prediction of Live Birth in GnRH Antagonist Protocol Fresh IVF/ICSI Cycles. [PDF]

Int J Womens Health
Zhong Y, Kang Q, Pang X, Wang N.
europepmc   +1 more source

A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol. [PDF]

Acta Obstet Gynecol Scand
Coelingh Bennink HJT, Afors K, Bahamondes L, Graziottin A, Bateson D, Bombas T, Osuga Y, Palacios S, Westhoff CL, Gemzell-Danielsson K.   +9 more
europepmc   +1 more source

Optimizing Ovarian Stimulation for IVF in PCOS Patients: A Novel Day 1 GnRH Antagonist Protocol. [PDF]

J Clin Med
Ghosh Dastidar S, Ghosh Dastidar B, Chattopadhyay R, Chakraborty C.   +3 more
europepmc   +1 more source